James E. Flynn - 27 Feb 2026 SCHEDULE 13D/A Report for Larimar Therapeutics, Inc. Common Stock, par value $0.01 per share (LRMR)

Filing Manager
James E. Flynn
Reporting Manager
Deerfield Management Company, L.P.
Security
Larimar Therapeutics, Inc. Common Stock, par value $0.01 per share
Symbol
LRMR
Shares outstanding
103,654,385 shares
Disclosed Ownership
35,667,474 shares
Ownership
34%
Form type
SCHEDULE 13D/A
Filing time
02 Mar 2026, 19:46:55 UTC
Date of event
27 Feb 2026
Previous filing
31 Jul 2025
SEC
View on sec.gov

Reporting Managers (10)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Deerfield Private Design Fund III, L.P. 10% 10,622,928 0 10,622,928 /s/ Jonathan Isler Jonathan Isler, Attorney-in-Fact 0001603333
Deerfield Healthcare Innovations Fund, L.P. 7.9% 8,153,107 0 8,153,107 /s/ Jonathan Isler Jonathan Isler, Attorney-in-Fact 0001646981
Deerfield Private Design Fund IV, L.P. 10% 10,622,957 0 10,622,957 /s/ Jonathan Isler Jonathan Isler, Attorney-in-Fact 0001680307
Deerfield Partners, L.P. 6% 6,207,982 0 6,207,982 /s/ Jonathan Isler Jonathan Isler, Attorney-in-Fact 0001301041
Deerfield Mgmt III, L.P. 10% 10,622,928 0 10,622,928 /s/ Jonathan Isler Jonathan Isler, Attorney-in-Fact 0001610540
Deerfield Mgmt HIF, L.P. 7.9% 8,153,107 0 8,153,107 /s/ Jonathan Isler Jonathan Isler, Attorney-in-Fact 0001665736
Deerfield Mgmt IV, L.P. 10% 10,622,957 0 10,622,957 /s/ Jonathan Isler Jonathan Isler, Attorney-in-Fact 0001713467
Deerfield Mgmt, L.P. 6% 6,207,982 0 6,207,982 /s/ Jonathan Isler Jonathan Isler, Attorney-in-Fact 0001010823
Deerfield Management Company, L.P. 34% 35,667,474 0 35,667,474 /s/ Jonathan Isler Jonathan Isler, Attorney-in-Fact 0001009258
James E. Flynn 34% 35,667,474 0 35,667,474 /s/ Jonathan Isler Jonathan Isler, Attorney-in-Fact 0001352546